PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer
The Pharma Data
JANUARY 24, 2021
– January 25, 2021) – PharmaDrug Inc. Food and Drug Administration (“FDA”) approval. Cepharanthine is a natural product and an approved drug used for more than 70 years in Japan to treat a variety of acute and chronic diseases. The global esophageal cancer drugs market is estimated to grow by USD $1.5
52 
Let's personalize your content